Addressing adolescent substance use with a public health prevention framework: the case for harm reduction

Abstract

Adolescence is a developmental stage defined in part by risk-taking. Risk-taking is critical to normal development and has important benefits including trying new activities and exploring new relationships. Risk-taking is also associated with the initiation of substance use. Because substance use often begins in adolescence, much focus has been on primary prevention with the goal of preventing initial substance use. Secondary or tertiary prevention approaches, such as counselling to eliminate substance use or offering treatment, are common approaches for adolescents with problematic substance use or a substance use disorder. While this is important, for some adolescents, treatment or cessation of use may not be desired. In these cases, Healthcare Practitioners (HCPs) can offer clear advice that incorporates harm reduction. Harm reduction, which is often applied for adults who use substances, reduces the negative impacts associated with drug use without requiring abstinence. Harm reduction is crucial to keeping adolescents safe and healthy and can offer opportunities for future engagement in treatment. The objective of this review is to describe strategies for integrating harm reduction principles in clinical settings that are developmentally appropriate. A patient-centered, harm reduction approach can validate perceived benefits of substance use, offer strategies to minimise harm, and advise reduction of use and abstinence. KEY MESSAGES: Substance use often begins in adolescence and traditional approaches are often rooted in prevention framework. Harm reduction should be incorporated for adolescents with problematic substance use or a substance use disorder. This review offers strategies for integration of harm reduction principles tailored towards adolescents.

Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: A call to action

“…Rapid development of oral-administration formulations of GLP-1RA and the proclivity among adolescents for risk-taking [ 10 ] create a perfect storm for potential abuse. Adolescence marks a particularly vulnerable period for the development of self-esteem and satisfaction with one’s own appearance.…”

Facilitators of and barriers to healthcare providers’ adoption of harm reduction in cannabis use: a scoping review protocol

“…However, PWUC intensively or at-risk populations (ie, pregnant persons, people presenting respiratory problems, a mental health comorbidity, having an early onset of continued tobacco use or concurrently smoking tobacco and cannabis) may develop a cannabis use disorder or experience harm at several levels 5 12 16–19. These harms may include a decreased academic or professional performance, a cognitive impairment, a deterioration of mental health (eg, development of psychosis or depression), an increased occurrence of risky behaviours (eg, cannabis-impaired driving), etc 3–5 12 14 18 20–22.…”

“…HR in cannabis use aims to minimise the harmful consequences of the substance at the individual, psychological, legal and social levels among PWUC 19 20 28 29. It offers a public health framework based on values of pragmatism and humanism, as it does not view substance use through a moral lens, but as an inevitable societal fact of long-standing 4 11 30 31.…”

“…HR in cannabis use aims to minimise the harmful consequences of the substance at the individual, psychological, legal and social levels among PWUC. 19 20 28 29 It offers a public health framework based on values of pragmatism and humanism, as it does not view substance use through a moral lens, but as an inevitable societal fact of long-standing. 4 11 30 31 Whether among adults or adolescents, elimination of substance use is unrealistic at the population level and should be the individual’s choice without being imposed, as it represents an unwanted and impractical goal for some (eg, in case of recreational or occasional use, in case of dual diagnosis combining psychiatric and substance use disorders).…”

Unintentional overdoses: understanding the fentanyl landscape and reducing harm

“…Harm reduction, which entails working to decrease the risk of injury or death without exclusively emphasizing abstinence, is essential for AYAs for several reasons [18,19 ▪ ,20 ▪ ]. AYAs report high levels of stigma around opioid use [21 ▪▪ ] and may be uncomfortable in opioid use disorder-treatment settings (e.g.…”